Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

Anxiety Clinical Trial

Official title: Personalized Feedback for Smokers With Elevated Anxiety Sensitivity

Status Completed

Clinical Trial Summary

This project will develop and refine a computer-delivered integrated Personalized Feedback Intervention (PFI) that directly addresses smoking and anxiety sensitivity (AS). The PFI will focus on feedback about smoking behavior, AS, and adaptive coping strategies.

Clinical Trial Description

The primary goal of the research study is to investigate the efficacy of a brief, personalized computer-delivered transdiagnostic intervention (PFI) that addresses smoking and anxiety sensitivity (AS) to reduce smoking, increase quit attempts, reduce perceived barriers to cessation, reduce AS and negative affective symptoms, and increase adaptive coping skills compared to a smoking information only control. To address this aim, we will implement a randomized controlled trial that will employ a longitudinal experimental design and involve three stages: (a) phone-screener (pre-screener); (b) baseline appointment consisting of a pre-intervention assessment (eligibility), random assignment to a one-session computer-delivered intervention (PFI versus smoking information control with no personalized feedback), and a post-intervention assessment; (c) 1-month follow-up. Assessments will include a multi-method approach, including biological, behavioral, and self-report methods. ;

Related Conditions & MeSH terms

• Anxiety
• Anxiety Disorders
• Hypersensitivity
• Smoking, Cigarette
• Smoking, Tobacco
• Tobacco Dependence
• Tobacco Use Disorder

• NCT number: NCT03382093
• Study type: Interventional
• Source: University of Houston
• Status: Completed
• Phase: N/A
• Start date: August 23, 2017
• Completion date: June 1, 2019